Knowledge management in R&D centres, in the field of biomedicine, using contemporary information and communication technology and the methodology of continuous improvement

- Ryszard Depta, Ph.D.

Some sophisticated medical applications, including advanced therapeutics with monoclonal antibodies, stem cells, and gene therapies are currently available in clinical trials. More revolutionary technologies are coming soon and will be marketed by the best technically advanced companies in the world. R&D companies with a much smaller indicator of technological progress and organizational efficiency, but with a great desire to become a major player in this industry, will also compete for a share of this market. However, in order to become a fixture in the changes initiated, both must constantly learn and be more innovative. In the current market situation, a hypercompetitive economy with the entrepreneurs’ focus on the prosumer, creativity is becoming extremely important in achieving final success. Creativity, which is the result of proper knowledge management, especially in science. The market value of R&D companies and their further future depends to a large extent on the prosperity of knowledge transfer. The most important role in the process of knowledge transfer is played by information and communication technologies (ICT) and tools for continuous improvement. If companies implement these efficiently and safely, they can develop and benefit from competitive advantages for a very long period of time. Such an approach would give them the possibility of reducing the cost and time to deliver new products to market, and create a new platform to generate innovative products. This is a new perspective for R&D businesses, and a great opportunity for institutions in the biomedical arena to become part of the upcoming bio-revolution.

dr Ryszard Depta , bio21GE, Poland – Doctor of Economics in management science (UEK-2015). In 2004, he completed a post-graduate course in biotechnology at the Jagiellonian University and an industrial pharmacy post-graduate programme in 2010. He is now involved in design and organisational work in the bio21GE start-up/think tank in the area of translational research in biomedicine. Earlier, holding the position of the Management Board Plenipotentiary, Head and Coordinator, he implemented solutions within GLP, ISO 17025 quality systems in the Wrocław Research Center EIT+ and the Jagiellonian Centre for Experimental Therapeutics, information systems (LIMS, BMS) and classified information and business secrets. He worked as the Senior Lean Consultant for Central and Eastern Europe in 2008-2009 and served as Master Black Belt at the Center of Excellence in France Telecom (Paris) from 2006-2007. He has been working in managerial positions in the telecommunications sector in the field of projects and processes (Katowice, Warsaw) for many years. He managed several different projects based on Lean Six Sigma, PMI and BPMN methodology and participated in many trainings conducted in Polish and foreign large production, service and extractive companies (e.g. in Japan, Netherlands, Scotland).

DOI: 10.14611/minib.17.03.2015.10

Kontakt: deprys(at)

MINIB, 2015, Vol. 17, Issue 3

Resize of Open_Access_logo_PLoS_white    Available in Open Access.


Read on-line →
Downloads: 316
Pobrano: 316